An Act relative to APOL1 mediated kidney disease

This bill (HD 4166) requires Massachusetts' Department of Public Health to study APOL1 gene variants linked to higher kidney disease risk. The department must issue a report by December 2026 with recommendations to increase awareness, screening, and genetic testing for these variants, plus analysis of funding strategies. The report will specifically address how to improve access to screening for Massachusetts residents affected by this genetic risk. It does not create new programs or funding but mandates a review to inform future health initiatives.